In a regulatory filing, MBX Biosciences (MBX) disclosed that its director Patrick Heron bought 667K shares of common stock on September 26th in a total transaction size of $12M. Shares of MBX Biosciences are up 4.9% afterhours.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBX: